Stereotaxis, Inc. (FRA:RJR1)

Market Cap	163.10M +29.4%
Revenue (ttm)	27.58M +20.3%
Net Income	-19.52M
EPS	-0.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	25
Open	1.636
Previous Close	1.646
Day's Range	1.608 - 1.650
52-Week Range	1.470 - 2.360
Beta	n/a
RSI	47.90
Earnings Date	May 12, 2026

About Stereotaxis

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Na...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1990
• Employees: 131
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJR1

Financial Performance

In 2025, Stereotaxis's revenue was $32.38 million, an increase of 20.28% compared to the previous year's $26.92 million. Losses were -$22.91 million, -9.62% less than in 2024.

Financial numbers in USD